Article Sidebar
Published:
Nov 16, 2024Keywords:
Article Details
On acceptance, the copyright of a manuscript will be vested in the journal and publisher. Articles published in Afrimedic journal are distributed under the terms of the Creative Commons Attribution License which allows for unrestricted use, distribution and reproduction in any medium, for any non-commercial purpose, subject to proper citation of the original work.
References
Stacy Leob, Annelies Vellekoop, Hashim U. Ahmed, James Catto, Mark Emberton, Robert Nam, Dereck J Rosario, VicenzoScattoni, YariLotan. Systematic review of complications of prostate biopsy. European Urol. 2013;64(6):876-892
Mathew R. Coopeeberg, Joseph C. Presti JR, Katsuto Shinohara, Peter R. Carrol. Neoplasm of the prostate gland. In: Jack W McAninch, Tom F. Lue eds. Smith and Tanagho’s General urology. 18th ed. McGraw Hill. 2013 pp 350-379
Wolf JS, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Schaeffer AJ, Pace KT. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol. 2012; 180(5): 2262-2263
Borghesi M, Ahmed H, Nam R, Schaeffer E, Schiavina R, Taneja S, et al. Complications after systematic, random, and image-guided prostate biopsy. EurUrol(2017) 71(3):353–365.
Ahmed HU, El-ShaterBosaily A, Brown LC et al: Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 2017; 389: 815
Liss MA, Ehdaie B, Loeb S et al: An update of the American Urological Association white paper on the prevention and treatment of the more common complications related to prostate biopsy. J Urol 2017; 198: 329.
Odo C, Afogu EN, Odoemene CA, Obi AO, Mbaeri TU, Obiesie EA et al. Prophylactic role of ciprofloxacin and ceftriaxone in prostate biopsy-related infection: randomized comparative study of bacterial spectrum and antibiotic sensitivities. African Journal of Urology 2021; 27:157-162
Doherty A. F., Ikuerowo S. O., Jeje E. A., Ibrahim N. A, Ojongbede O. L., Mutiu W. Bet. al prospective randomized comparative study of targeted versus empirical prophylactic antibiotics in the of infective complication following transrectal ultrasound-guided prostate biopsy. Annals of African Medicine 2019; 18(3)132-137
Chukwu E.E., Oladele D. A., Awoderu O.B, Afocha E.E, Lawal R.G, Abdus-salam I et al. A national survey of public awareness of antimicrobial resistance in Nigeria. Antimicrob Resist Infect Control. 2020; 9:72-81
Liss MA, Chang A, Santos R, Nakama Peeples A, Peterson EM, Osann K, et al. Prevalence and significance of fluoroquinolone-resistant Escherichia coli in patients undergoing transrectal ultrasound-guided prostate needle biopsy. J Urol 2011; 185:1283 1288.
Bonkat G, Pilatz A and Wagenlehner F: Time to adapt our practice? The European Commission has restricted the use of fluoroquinolones since March 2019. EurUrol 2019; 76: 273.
JA Karlowsky, LJ Kelly, C Thornsberry, ME Jones, AT Evangelista, IA Critchley, DF Sahm. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking resistance in the United States today. The surveillance network. Int J Antimicrob Agents, 2002; 19:21–31
Marino K, Parlee A, Orlando R, Lerner L, Strymish J, GuptaK. Comparative effectiveness of single versus combination antibiotic prophylaxis for infections after transrectal prostate biopsy. Antimicrob Agents Chemother. 2015; 59 (12): 7273-7275.
Main Article Content
Prophylactic role of ciprofloxacin and ceftriaxone in prostate biopsy-related infection time to Adopt new strategy
Abstract
No Abstract
Cite this article as: Odo C, Ulebe A.O, Oguonu A.C, Obi A.O, Mbaeri T.U, Obiesie E.A, Okeke C.J, Nnadozie U.U, Nzeako C.H.
Prophylactic Role of Ciprofloxacin And Ceftriaxone In Prostate Biopsy-Related Infection: Time To Adopt New Strategy.
Afrimedic Journal 2024; 10(2): 1-3.
